IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BERRUTI, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.005
EU - Europa 8.799
AS - Asia 7.227
SA - Sud America 41
AF - Africa 24
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 16
Totale 41.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.934
UA - Ucraina 2.685
CN - Cina 2.484
SG - Singapore 2.425
HK - Hong Kong 1.406
DE - Germania 1.232
IT - Italia 1.169
PL - Polonia 876
RU - Federazione Russa 631
TR - Turchia 521
IE - Irlanda 511
FI - Finlandia 476
GB - Regno Unito 436
EE - Estonia 190
FR - Francia 187
IN - India 110
CZ - Repubblica Ceca 106
VN - Vietnam 81
ID - Indonesia 77
SE - Svezia 75
CA - Canada 57
BE - Belgio 53
NL - Olanda 52
AT - Austria 35
CH - Svizzera 20
AU - Australia 19
BR - Brasile 19
JP - Giappone 19
EU - Europa 16
KR - Corea 14
AZ - Azerbaigian 10
IR - Iran 9
PT - Portogallo 9
MA - Marocco 8
KG - Kirghizistan 7
KZ - Kazakistan 7
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
LT - Lituania 6
PA - Panama 6
PK - Pakistan 6
DK - Danimarca 5
ES - Italia 5
MU - Mauritius 5
RO - Romania 5
AM - Armenia 4
BO - Bolivia 4
CL - Cile 4
GR - Grecia 4
IL - Israele 4
LK - Sri Lanka 4
NO - Norvegia 4
TW - Taiwan 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
EC - Ecuador 3
GE - Georgia 3
IQ - Iraq 3
IS - Islanda 3
LA - Repubblica Popolare Democratica del Laos 3
MX - Messico 3
NZ - Nuova Zelanda 3
PE - Perù 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
CY - Cipro 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
TH - Thailandia 2
ZW - Zimbabwe 2
BD - Bangladesh 1
BY - Bielorussia 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
TN - Tunisia 1
Totale 41.134
Salva come PNG Salva come JPEG
Città #
Fairfield 4.232
Woodbridge 3.240
Houston 2.187
Ashburn 1.884
Jacksonville 1.876
Seattle 1.721
Cambridge 1.594
Singapore 1.420
Hong Kong 1.400
Ann Arbor 1.362
Wilmington 1.342
Princeton 879
Warsaw 871
Chandler 727
Beijing 548
New York 519
Dublin 469
Nanjing 469
Istanbul 457
Helsinki 397
Brescia 233
Des Moines 230
Dearborn 199
Tallinn 190
Moscow 188
Nanchang 186
San Diego 181
Shanghai 139
Shenyang 137
Changsha 134
Hebei 133
Boardman 132
Milan 128
Los Angeles 97
Jinan 86
London 85
Tianjin 84
Brno 80
Dong Ket 80
Jakarta 75
Jiaxing 67
Munich 66
Dalmine 60
Romola 57
Orange 56
Hangzhou 55
Brussels 52
Kocaeli 51
Verona 51
Kunming 48
Nuremberg 46
San Francisco 44
West Jordan 38
Rome 36
Washington 35
Toronto 32
Calcinate 31
Ningbo 30
Zhengzhou 30
Lanzhou 26
Nürnberg 26
Naples 25
Kilburn 24
Olomouc 24
Haikou 23
Norwalk 23
Menlo Park 22
Guangzhou 21
Phoenix 21
Lancaster 20
Pune 20
San Mateo 19
Santa Clara 19
Taizhou 19
Redwood City 17
Changchun 16
Augusta 15
Hefei 15
Leawood 15
North York 15
Vienna 15
Acton 14
Chicago 14
Falkenstein 13
New Bedfont 13
Falls Church 12
Lappeenranta 12
Chiswick 11
Fuzhou 11
Newark 11
Mumbai 10
Prescot 10
Turin 10
Walnut 10
Canberra 9
Espoo 9
Gumyojicho 9
Zurich 9
Ardabil 8
Baku 8
Totale 31.919
Salva come PNG Salva come JPEG
Nome #
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 247
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 225
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 209
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 199
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 198
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review 185
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 184
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 184
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 180
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 177
Immunotherapy failure in adrenocortical cancer: where next? 168
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 167
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 166
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 165
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 160
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 160
Pros-IT CNR: an Italian prostate cancer monitoring project 158
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 157
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 155
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 154
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 154
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 152
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 149
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 148
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 146
Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease 146
Palbociclib inhibits proliferation of human adrenocortical tumor cells 145
Regression of advanced neuroendocrine tumors among patients receiving placebo 145
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 141
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 140
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients 140
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 139
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 139
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 138
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 137
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 136
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 136
Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method 135
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 135
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 134
828PBONE METASTASES FROM RCC ARE NOT ALWAYS ASSOCIATED WITH A POOR PROGNOSIS 134
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 133
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 132
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 132
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 131
Exemestane with ovarian suppression in premenopausal breast cancer. 131
Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer 130
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 130
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 129
Serum vitamin D and prostate cancer prognosis: The story continues 129
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 129
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 128
A Rare Complex BRAF Mutation Involving Codon V600 and K601 in Primary Cutaneous Melanoma: Case Report 127
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 124
Prognostic factors in patients receiving third-line targeted therapy for metastatic renal cell carcinoma. 123
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 122
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 122
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 121
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 121
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 119
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer. 117
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 117
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 117
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 117
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 117
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 117
Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy worse radical cystectomy outcomes in frails 117
Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases. 116
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 116
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 116
5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma 115
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 115
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 115
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study 114
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 114
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 114
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 114
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. 112
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 112
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. 112
Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery. 112
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 112
The pathological diagnosis of neuroendocrine tumors: Common questions and tentative answers 112
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 111
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 111
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. 111
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 111
An unusual case of a well-differentiated neuroendocrine tumour of the ileum with peritoneal carcinomatosis: A case report 110
Abiraterone and increased survival in metastatic prostate cancer 110
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment. 109
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): An European Network for the Study of Adrenal Tumor (ENSAT) study 109
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 109
Real-world study of everolimus in advanced progressive neuroendocrine tumors. 108
Follow-up and quality of life 108
Effect of primary letrozole treatment on tumor expression of mTOR and HIF-1α and relation to clinical response 108
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. 107
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 107
Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer. 107
Combination chemotherapy in advanced adrenocortical carcinoma 107
A current perspective on treatment of adrenocortical carcinoma 107
Totale 13.470
Salva come PNG Salva come JPEG
Categoria #
all - tutte 235.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.069 0 0 0 0 0 0 0 0 1.038 1.093 336 602
2020/20217.465 202 836 390 854 400 777 392 786 619 1.174 650 385
2021/20223.503 274 702 93 213 50 182 214 234 194 349 267 731
2022/20232.586 497 83 74 178 191 712 10 212 347 44 115 123
2023/20243.948 180 96 316 217 207 696 109 145 1.039 118 48 777
2024/20255.637 98 74 98 1.510 1.168 737 591 293 1.068 0 0 0
Totale 42.138